Lamivudine Articles & Analysis
2 news found
Aurobindo Pharma Limited is pleased to announce that the company has received approval from the South African Health Products Regulatory Authority (SAHPRA) for its Dolutegravir, Lamivudine and Tenofovir Disoproxil Fumarate (DLT) tablets, 50mg/300mg/300mg, the first-line preferred regimen for HIV patients as per latest WHO guidelines. ...
ViiV Healthcare acknowledges the contribution of Shire Pharmaceuticals, which has licensed the rights to products containing lamivudine to ViiV Healthcare; and of Shionogi, co-developer of the integrase inhibitor with ViiV Healthcare; who have both agreed to waive their rights to royalty payments for these countries in order to improve access for these products. ...